Keryx Biopharmaceuticals Inc fka KERX

[FredKerx]

Fellow investors, just so you understand Auryxia’s blockbuster potential and the insane screw-job that Keryx shareholders are facing with Kerx’s pps at sub-$5 going on 5 MONTHS since IDA approval..

https://www.medscape.org/viewarticle/876836_2

Kerx’s pps should be at $10 minimum, and that’s only because of the level of dilution the “gangstas” have employed over the past 4 years (including conv. notes and addtl. $75 supplement, without $100 million remaining shelf, outstanding shares at some 170 million).

Screw-job dilution while subsidizing hefty compensation packsges and excessive options while delivering nothing but nightmares for shareholders. But, as goes the hypothetical, the “plot” goes DEEP..

ALL IMO